Search Results

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Q-TWiST analysis of sacituzumab govitecan vs. chemotherapy in previously treated patients with HR+/HER2− metastatic breast cancer by Rugo, Hope S. (Author) , Bardia, Aditya (Author) , Schmid, Peter (Author) , Tolaney, Sara M. (Author) , Dasgupta, Anandaroop (Author) , Kaushik, Ankita (Author) , Verret, Wendy (Author) , Gosset, Marine (Author) , Brufsky, Adam (Author) , Cortés, Javier (Author) , Marmé, Frederik (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    A plain language summary of the TROPiCS-02 study in patients with breast cancer (HR-positive/HER2-negative) by Rugo, Hope S. (Author) , Bardia, Aditya (Author) , Marmé, Frederik (Author) , Cortes, Javier (Author) , Schmid, Peter (Author) , Spears, Patricia A. (Author) , Tolaney, Sara M. (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Sacituzumab govitecan: past, present and future of a new antibody-drug conjugate and future horizon: drug evaluation by Furlanetto, Jenny (Author) , Marmé, Frederik (Author) , Loibl, Sibylle (Author) ,


    Get full text
    Article (Journal) Online Resource